Global Autoimmune Monoclonal Antibodies Production, Demand and Key Producers, 2022-2028
Autoimmune diseases are the condition in which body own immune system mistakenly attack normal body. In autoimmune diseases production of autoantibodies occurs which attack the healthy cell of body. Autoimmune monoclonal antibodies are the agents which acts as immunotherapy agent and protect the body healthy cell from the damage.
This report studies the global Autoimmune Monoclonal Antibodies production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Autoimmune Monoclonal Antibodies, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Autoimmune Monoclonal Antibodies that contribute to its increasing demand across many markets.
The global Autoimmune Monoclonal Antibodies market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Autoimmune Monoclonal Antibodies total production and demand, 2017-2028, (K Units)
Global Autoimmune Monoclonal Antibodies total production value, 2017-2028, (USD Million)
Global Autoimmune Monoclonal Antibodies production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Autoimmune Monoclonal Antibodies consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Autoimmune Monoclonal Antibodies domestic production, consumption, key domestic manufacturers and share
Global Autoimmune Monoclonal Antibodies production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Autoimmune Monoclonal Antibodies production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Autoimmune Monoclonal Antibodies production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Autoimmune Monoclonal Antibodies market based on the following parameters – headquarters, production locations, products portfolio, Autoimmune Monoclonal Antibodies revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Autoimmune Monoclonal Antibodies market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Autoimmune Monoclonal Antibodies Market, By Region:
1. How big is the global Autoimmune Monoclonal Antibodies market?
2. What is the demand of the global Autoimmune Monoclonal Antibodies market?
3. What is the year over year growth of the global Autoimmune Monoclonal Antibodies market?
4. What is the production and production value of the global Autoimmune Monoclonal Antibodies market?
5. Who are the key producers in the global Autoimmune Monoclonal Antibodies market?
6. What are the growth factors driving the market demand?
This report studies the global Autoimmune Monoclonal Antibodies production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Autoimmune Monoclonal Antibodies, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Autoimmune Monoclonal Antibodies that contribute to its increasing demand across many markets.
The global Autoimmune Monoclonal Antibodies market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Autoimmune Monoclonal Antibodies total production and demand, 2017-2028, (K Units)
Global Autoimmune Monoclonal Antibodies total production value, 2017-2028, (USD Million)
Global Autoimmune Monoclonal Antibodies production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Autoimmune Monoclonal Antibodies consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Autoimmune Monoclonal Antibodies domestic production, consumption, key domestic manufacturers and share
Global Autoimmune Monoclonal Antibodies production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Autoimmune Monoclonal Antibodies production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Autoimmune Monoclonal Antibodies production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Autoimmune Monoclonal Antibodies market based on the following parameters – headquarters, production locations, products portfolio, Autoimmune Monoclonal Antibodies revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Autoimmune Monoclonal Antibodies market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Autoimmune Monoclonal Antibodies Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- TNF Class
- Interleukins
- Integrins
- B-Cell Depletion and Inhibition Targets
- T Cell Depletion Targets
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
- Multiple Sclerosis
- Organ Transplant Rejection
- Others
- F. Hoffmann-La Roche Ltd
- Mylan N.V
- Sanofi
- Pfizer Inc
- GSK plc
- Novartis AG
- Bayer AG
- Lilly
- Merck & Co., Inc
- Sun Pharmaceutical Industries Ltd
- Aurobindo Pharma
- Lupin
- Fresenius Kabi AG
- Akorn Incorporated
- Teva Pharmaceutical Industries Ltd
1. How big is the global Autoimmune Monoclonal Antibodies market?
2. What is the demand of the global Autoimmune Monoclonal Antibodies market?
3. What is the year over year growth of the global Autoimmune Monoclonal Antibodies market?
4. What is the production and production value of the global Autoimmune Monoclonal Antibodies market?
5. Who are the key producers in the global Autoimmune Monoclonal Antibodies market?
6. What are the growth factors driving the market demand?
'@LOT1 SUPPLY SUMMARY
1.1 Autoimmune Monoclonal Antibodies Introduction
1.2 World Autoimmune Monoclonal Antibodies Supply & Forecast
1.2.1 World Autoimmune Monoclonal Antibodies Production Value (2017 & 2021 & 2028)
1.2.2 World Autoimmune Monoclonal Antibodies Production (2017-2028)
1.2.3 World Autoimmune Monoclonal Antibodies Pricing Trends (2017-2028)
1.3 World Autoimmune Monoclonal Antibodies Production by Region
1.3.1 World Autoimmune Monoclonal Antibodies Production Value by Region (2017-2028)
1.3.2 World Autoimmune Monoclonal Antibodies Production by Region (2017-2028)
1.3.3 World Autoimmune Monoclonal Antibodies Average Price by Region (2017-2028)
1.3.4 North America Autoimmune Monoclonal Antibodies Production (2017-2028)
1.3.5 Europe Autoimmune Monoclonal Antibodies Production (2017-2028)
1.3.6 China Autoimmune Monoclonal Antibodies Production (2017-2028)
1.3.7 Japan Autoimmune Monoclonal Antibodies Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Autoimmune Monoclonal Antibodies Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Autoimmune Monoclonal Antibodies Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Autoimmune Monoclonal Antibodies Demand (2017-2028)
2.2 World Autoimmune Monoclonal Antibodies Consumption by Region
2.2.1 World Autoimmune Monoclonal Antibodies Consumption by Region (2017-2022)
2.2.2 World Autoimmune Monoclonal Antibodies Consumption Forecast by Region (2023-2028)
2.3 United States Autoimmune Monoclonal Antibodies Consumption (2017-2028)
2.4 China Autoimmune Monoclonal Antibodies Consumption (2017-2028)
2.5 Europe Autoimmune Monoclonal Antibodies Consumption (2017-2028)
2.6 Japan Autoimmune Monoclonal Antibodies Consumption (2017-2028)
2.7 South Korea Autoimmune Monoclonal Antibodies Consumption (2017-2028)
2.8 ASEAN Autoimmune Monoclonal Antibodies Consumption (2017-2028)
2.9 India Autoimmune Monoclonal Antibodies Consumption (2017-2028)
3 WORLD AUTOIMMUNE MONOCLONAL ANTIBODIES MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Autoimmune Monoclonal Antibodies Production Value by Manufacturer (2017-2022)
3.2 World Autoimmune Monoclonal Antibodies Production by Manufacturer (2017-2022)
3.3 World Autoimmune Monoclonal Antibodies Average Price by Manufacturer (2017-2022)
3.4 Autoimmune Monoclonal Antibodies Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Autoimmune Monoclonal Antibodies Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Autoimmune Monoclonal Antibodies in 2021
3.5.3 Global Concentration Ratios (CR8) for Autoimmune Monoclonal Antibodies in 2021
3.6 Autoimmune Monoclonal Antibodies Market: Overall Company Footprint Analysis
3.6.1 Autoimmune Monoclonal Antibodies Market: Region Footprint
3.6.2 Autoimmune Monoclonal Antibodies Market: Company Product Type Footprint
3.6.3 Autoimmune Monoclonal Antibodies Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Autoimmune Monoclonal Antibodies Production Value Comparison
4.1.1 United States VS China: Autoimmune Monoclonal Antibodies Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Autoimmune Monoclonal Antibodies Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Autoimmune Monoclonal Antibodies Production Comparison
4.2.1 United States VS China: Autoimmune Monoclonal Antibodies Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Autoimmune Monoclonal Antibodies Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Autoimmune Monoclonal Antibodies Consumption Comparison
4.3.1 United States VS China: Autoimmune Monoclonal Antibodies Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Autoimmune Monoclonal Antibodies Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Autoimmune Monoclonal Antibodies Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Autoimmune Monoclonal Antibodies in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Autoimmune Monoclonal Antibodies Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Autoimmune Monoclonal Antibodies Production by Domestic Manufacturer, (2017-2022)
4.5 China Autoimmune Monoclonal Antibodies Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Autoimmune Monoclonal Antibodies in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Autoimmune Monoclonal Antibodies Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Autoimmune Monoclonal Antibodies Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Autoimmune Monoclonal Antibodies Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Autoimmune Monoclonal Antibodies in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Autoimmune Monoclonal Antibodies Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Autoimmune Monoclonal Antibodies Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Autoimmune Monoclonal Antibodies Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 TNF Class
5.2.2 Interleukins
5.2.3 Integrins
5.2.4 B-Cell Depletion and Inhibition Targets
5.2.5 T Cell Depletion Targets
5.3 Market Segment by Type
5.3.1 World Autoimmune Monoclonal Antibodies Production by Type (2017-2028)
5.3.2 World Autoimmune Monoclonal Antibodies Production Value by Type (2017-2028)
5.3.3 World Autoimmune Monoclonal Antibodies Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Autoimmune Monoclonal Antibodies Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Rheumatoid Arthritis
6.2.2 Systemic Lupus Erythematosus
6.2.3 Multiple Sclerosis
6.2.4 Organ Transplant Rejection
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Autoimmune Monoclonal Antibodies Production by Application (2017-2028)
6.3.2 World Autoimmune Monoclonal Antibodies Production Value by Application (2017-2028)
6.3.3 World Autoimmune Monoclonal Antibodies Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 F. Hoffmann-La Roche Ltd
7.1.1 F. Hoffmann-La Roche Ltd Details
7.1.2 F. Hoffmann-La Roche Ltd Major Business
7.1.3 F. Hoffmann-La Roche Ltd Autoimmune Monoclonal Antibodies Product and Services
7.1.4 F. Hoffmann-La Roche Ltd Autoimmune Monoclonal Antibodies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
7.1.6 F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
7.2 Mylan N.V
7.2.1 Mylan N.V Details
7.2.2 Mylan N.V Major Business
7.2.3 Mylan N.V Autoimmune Monoclonal Antibodies Product and Services
7.2.4 Mylan N.V Autoimmune Monoclonal Antibodies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Mylan N.V Recent Developments/Updates
7.2.6 Mylan N.V Competitive Strengths & Weaknesses
7.3 Sanofi
7.3.1 Sanofi Details
7.3.2 Sanofi Major Business
7.3.3 Sanofi Autoimmune Monoclonal Antibodies Product and Services
7.3.4 Sanofi Autoimmune Monoclonal Antibodies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Sanofi Recent Developments/Updates
7.3.6 Sanofi Competitive Strengths & Weaknesses
7.4 Pfizer Inc
7.4.1 Pfizer Inc Details
7.4.2 Pfizer Inc Major Business
7.4.3 Pfizer Inc Autoimmune Monoclonal Antibodies Product and Services
7.4.4 Pfizer Inc Autoimmune Monoclonal Antibodies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Pfizer Inc Recent Developments/Updates
7.4.6 Pfizer Inc Competitive Strengths & Weaknesses
7.5 GSK plc
7.5.1 GSK plc Details
7.5.2 GSK plc Major Business
7.5.3 GSK plc Autoimmune Monoclonal Antibodies Product and Services
7.5.4 GSK plc Autoimmune Monoclonal Antibodies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 GSK plc Recent Developments/Updates
7.5.6 GSK plc Competitive Strengths & Weaknesses
7.6 Novartis AG
7.6.1 Novartis AG Details
7.6.2 Novartis AG Major Business
7.6.3 Novartis AG Autoimmune Monoclonal Antibodies Product and Services
7.6.4 Novartis AG Autoimmune Monoclonal Antibodies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Novartis AG Recent Developments/Updates
7.6.6 Novartis AG Competitive Strengths & Weaknesses
7.7 Bayer AG
7.7.1 Bayer AG Details
7.7.2 Bayer AG Major Business
7.7.3 Bayer AG Autoimmune Monoclonal Antibodies Product and Services
7.7.4 Bayer AG Autoimmune Monoclonal Antibodies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Bayer AG Recent Developments/Updates
7.7.6 Bayer AG Competitive Strengths & Weaknesses
7.8 Lilly
7.8.1 Lilly Details
7.8.2 Lilly Major Business
7.8.3 Lilly Autoimmune Monoclonal Antibodies Product and Services
7.8.4 Lilly Autoimmune Monoclonal Antibodies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Lilly Recent Developments/Updates
7.8.6 Lilly Competitive Strengths & Weaknesses
7.9 Merck & Co., Inc
7.9.1 Merck & Co., Inc Details
7.9.2 Merck & Co., Inc Major Business
7.9.3 Merck & Co., Inc Autoimmune Monoclonal Antibodies Product and Services
7.9.4 Merck & Co., Inc Autoimmune Monoclonal Antibodies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Merck & Co., Inc Recent Developments/Updates
7.9.6 Merck & Co., Inc Competitive Strengths & Weaknesses
7.10 Sun Pharmaceutical Industries Ltd
7.10.1 Sun Pharmaceutical Industries Ltd Details
7.10.2 Sun Pharmaceutical Industries Ltd Major Business
7.10.3 Sun Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Product and Services
7.10.4 Sun Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
7.10.6 Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.11 Aurobindo Pharma
7.11.1 Aurobindo Pharma Details
7.11.2 Aurobindo Pharma Major Business
7.11.3 Aurobindo Pharma Autoimmune Monoclonal Antibodies Product and Services
7.11.4 Aurobindo Pharma Autoimmune Monoclonal Antibodies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Aurobindo Pharma Recent Developments/Updates
7.11.6 Aurobindo Pharma Competitive Strengths & Weaknesses
7.12 Lupin
7.12.1 Lupin Details
7.12.2 Lupin Major Business
7.12.3 Lupin Autoimmune Monoclonal Antibodies Product and Services
7.12.4 Lupin Autoimmune Monoclonal Antibodies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Lupin Recent Developments/Updates
7.12.6 Lupin Competitive Strengths & Weaknesses
7.13 Fresenius Kabi AG
7.13.1 Fresenius Kabi AG Details
7.13.2 Fresenius Kabi AG Major Business
7.13.3 Fresenius Kabi AG Autoimmune Monoclonal Antibodies Product and Services
7.13.4 Fresenius Kabi AG Autoimmune Monoclonal Antibodies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Fresenius Kabi AG Recent Developments/Updates
7.13.6 Fresenius Kabi AG Competitive Strengths & Weaknesses
7.14 Akorn Incorporated
7.14.1 Akorn Incorporated Details
7.14.2 Akorn Incorporated Major Business
7.14.3 Akorn Incorporated Autoimmune Monoclonal Antibodies Product and Services
7.14.4 Akorn Incorporated Autoimmune Monoclonal Antibodies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Akorn Incorporated Recent Developments/Updates
7.14.6 Akorn Incorporated Competitive Strengths & Weaknesses
7.15 Teva Pharmaceutical Industries Ltd
7.15.1 Teva Pharmaceutical Industries Ltd Details
7.15.2 Teva Pharmaceutical Industries Ltd Major Business
7.15.3 Teva Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Product and Services
7.15.4 Teva Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.15.6 Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Autoimmune Monoclonal Antibodies and Key Manufacturers
8.2 Autoimmune Monoclonal Antibodies Manufacturing Costs
8.3 Autoimmune Monoclonal Antibodies Production Process
8.4 Autoimmune Monoclonal Antibodies Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Autoimmune Monoclonal Antibodies Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Autoimmune Monoclonal Antibodies Typical Distributors
9.3 Autoimmune Monoclonal Antibodies Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Autoimmune Monoclonal Antibodies Introduction
1.2 World Autoimmune Monoclonal Antibodies Supply & Forecast
1.2.1 World Autoimmune Monoclonal Antibodies Production Value (2017 & 2021 & 2028)
1.2.2 World Autoimmune Monoclonal Antibodies Production (2017-2028)
1.2.3 World Autoimmune Monoclonal Antibodies Pricing Trends (2017-2028)
1.3 World Autoimmune Monoclonal Antibodies Production by Region
1.3.1 World Autoimmune Monoclonal Antibodies Production Value by Region (2017-2028)
1.3.2 World Autoimmune Monoclonal Antibodies Production by Region (2017-2028)
1.3.3 World Autoimmune Monoclonal Antibodies Average Price by Region (2017-2028)
1.3.4 North America Autoimmune Monoclonal Antibodies Production (2017-2028)
1.3.5 Europe Autoimmune Monoclonal Antibodies Production (2017-2028)
1.3.6 China Autoimmune Monoclonal Antibodies Production (2017-2028)
1.3.7 Japan Autoimmune Monoclonal Antibodies Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Autoimmune Monoclonal Antibodies Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Autoimmune Monoclonal Antibodies Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Autoimmune Monoclonal Antibodies Demand (2017-2028)
2.2 World Autoimmune Monoclonal Antibodies Consumption by Region
2.2.1 World Autoimmune Monoclonal Antibodies Consumption by Region (2017-2022)
2.2.2 World Autoimmune Monoclonal Antibodies Consumption Forecast by Region (2023-2028)
2.3 United States Autoimmune Monoclonal Antibodies Consumption (2017-2028)
2.4 China Autoimmune Monoclonal Antibodies Consumption (2017-2028)
2.5 Europe Autoimmune Monoclonal Antibodies Consumption (2017-2028)
2.6 Japan Autoimmune Monoclonal Antibodies Consumption (2017-2028)
2.7 South Korea Autoimmune Monoclonal Antibodies Consumption (2017-2028)
2.8 ASEAN Autoimmune Monoclonal Antibodies Consumption (2017-2028)
2.9 India Autoimmune Monoclonal Antibodies Consumption (2017-2028)
3 WORLD AUTOIMMUNE MONOCLONAL ANTIBODIES MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Autoimmune Monoclonal Antibodies Production Value by Manufacturer (2017-2022)
3.2 World Autoimmune Monoclonal Antibodies Production by Manufacturer (2017-2022)
3.3 World Autoimmune Monoclonal Antibodies Average Price by Manufacturer (2017-2022)
3.4 Autoimmune Monoclonal Antibodies Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Autoimmune Monoclonal Antibodies Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Autoimmune Monoclonal Antibodies in 2021
3.5.3 Global Concentration Ratios (CR8) for Autoimmune Monoclonal Antibodies in 2021
3.6 Autoimmune Monoclonal Antibodies Market: Overall Company Footprint Analysis
3.6.1 Autoimmune Monoclonal Antibodies Market: Region Footprint
3.6.2 Autoimmune Monoclonal Antibodies Market: Company Product Type Footprint
3.6.3 Autoimmune Monoclonal Antibodies Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Autoimmune Monoclonal Antibodies Production Value Comparison
4.1.1 United States VS China: Autoimmune Monoclonal Antibodies Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Autoimmune Monoclonal Antibodies Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Autoimmune Monoclonal Antibodies Production Comparison
4.2.1 United States VS China: Autoimmune Monoclonal Antibodies Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Autoimmune Monoclonal Antibodies Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Autoimmune Monoclonal Antibodies Consumption Comparison
4.3.1 United States VS China: Autoimmune Monoclonal Antibodies Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Autoimmune Monoclonal Antibodies Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Autoimmune Monoclonal Antibodies Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Autoimmune Monoclonal Antibodies in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Autoimmune Monoclonal Antibodies Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Autoimmune Monoclonal Antibodies Production by Domestic Manufacturer, (2017-2022)
4.5 China Autoimmune Monoclonal Antibodies Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Autoimmune Monoclonal Antibodies in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Autoimmune Monoclonal Antibodies Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Autoimmune Monoclonal Antibodies Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Autoimmune Monoclonal Antibodies Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Autoimmune Monoclonal Antibodies in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Autoimmune Monoclonal Antibodies Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Autoimmune Monoclonal Antibodies Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Autoimmune Monoclonal Antibodies Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 TNF Class
5.2.2 Interleukins
5.2.3 Integrins
5.2.4 B-Cell Depletion and Inhibition Targets
5.2.5 T Cell Depletion Targets
5.3 Market Segment by Type
5.3.1 World Autoimmune Monoclonal Antibodies Production by Type (2017-2028)
5.3.2 World Autoimmune Monoclonal Antibodies Production Value by Type (2017-2028)
5.3.3 World Autoimmune Monoclonal Antibodies Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Autoimmune Monoclonal Antibodies Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Rheumatoid Arthritis
6.2.2 Systemic Lupus Erythematosus
6.2.3 Multiple Sclerosis
6.2.4 Organ Transplant Rejection
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Autoimmune Monoclonal Antibodies Production by Application (2017-2028)
6.3.2 World Autoimmune Monoclonal Antibodies Production Value by Application (2017-2028)
6.3.3 World Autoimmune Monoclonal Antibodies Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 F. Hoffmann-La Roche Ltd
7.1.1 F. Hoffmann-La Roche Ltd Details
7.1.2 F. Hoffmann-La Roche Ltd Major Business
7.1.3 F. Hoffmann-La Roche Ltd Autoimmune Monoclonal Antibodies Product and Services
7.1.4 F. Hoffmann-La Roche Ltd Autoimmune Monoclonal Antibodies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
7.1.6 F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
7.2 Mylan N.V
7.2.1 Mylan N.V Details
7.2.2 Mylan N.V Major Business
7.2.3 Mylan N.V Autoimmune Monoclonal Antibodies Product and Services
7.2.4 Mylan N.V Autoimmune Monoclonal Antibodies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Mylan N.V Recent Developments/Updates
7.2.6 Mylan N.V Competitive Strengths & Weaknesses
7.3 Sanofi
7.3.1 Sanofi Details
7.3.2 Sanofi Major Business
7.3.3 Sanofi Autoimmune Monoclonal Antibodies Product and Services
7.3.4 Sanofi Autoimmune Monoclonal Antibodies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Sanofi Recent Developments/Updates
7.3.6 Sanofi Competitive Strengths & Weaknesses
7.4 Pfizer Inc
7.4.1 Pfizer Inc Details
7.4.2 Pfizer Inc Major Business
7.4.3 Pfizer Inc Autoimmune Monoclonal Antibodies Product and Services
7.4.4 Pfizer Inc Autoimmune Monoclonal Antibodies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Pfizer Inc Recent Developments/Updates
7.4.6 Pfizer Inc Competitive Strengths & Weaknesses
7.5 GSK plc
7.5.1 GSK plc Details
7.5.2 GSK plc Major Business
7.5.3 GSK plc Autoimmune Monoclonal Antibodies Product and Services
7.5.4 GSK plc Autoimmune Monoclonal Antibodies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 GSK plc Recent Developments/Updates
7.5.6 GSK plc Competitive Strengths & Weaknesses
7.6 Novartis AG
7.6.1 Novartis AG Details
7.6.2 Novartis AG Major Business
7.6.3 Novartis AG Autoimmune Monoclonal Antibodies Product and Services
7.6.4 Novartis AG Autoimmune Monoclonal Antibodies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Novartis AG Recent Developments/Updates
7.6.6 Novartis AG Competitive Strengths & Weaknesses
7.7 Bayer AG
7.7.1 Bayer AG Details
7.7.2 Bayer AG Major Business
7.7.3 Bayer AG Autoimmune Monoclonal Antibodies Product and Services
7.7.4 Bayer AG Autoimmune Monoclonal Antibodies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Bayer AG Recent Developments/Updates
7.7.6 Bayer AG Competitive Strengths & Weaknesses
7.8 Lilly
7.8.1 Lilly Details
7.8.2 Lilly Major Business
7.8.3 Lilly Autoimmune Monoclonal Antibodies Product and Services
7.8.4 Lilly Autoimmune Monoclonal Antibodies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Lilly Recent Developments/Updates
7.8.6 Lilly Competitive Strengths & Weaknesses
7.9 Merck & Co., Inc
7.9.1 Merck & Co., Inc Details
7.9.2 Merck & Co., Inc Major Business
7.9.3 Merck & Co., Inc Autoimmune Monoclonal Antibodies Product and Services
7.9.4 Merck & Co., Inc Autoimmune Monoclonal Antibodies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Merck & Co., Inc Recent Developments/Updates
7.9.6 Merck & Co., Inc Competitive Strengths & Weaknesses
7.10 Sun Pharmaceutical Industries Ltd
7.10.1 Sun Pharmaceutical Industries Ltd Details
7.10.2 Sun Pharmaceutical Industries Ltd Major Business
7.10.3 Sun Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Product and Services
7.10.4 Sun Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
7.10.6 Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.11 Aurobindo Pharma
7.11.1 Aurobindo Pharma Details
7.11.2 Aurobindo Pharma Major Business
7.11.3 Aurobindo Pharma Autoimmune Monoclonal Antibodies Product and Services
7.11.4 Aurobindo Pharma Autoimmune Monoclonal Antibodies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Aurobindo Pharma Recent Developments/Updates
7.11.6 Aurobindo Pharma Competitive Strengths & Weaknesses
7.12 Lupin
7.12.1 Lupin Details
7.12.2 Lupin Major Business
7.12.3 Lupin Autoimmune Monoclonal Antibodies Product and Services
7.12.4 Lupin Autoimmune Monoclonal Antibodies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Lupin Recent Developments/Updates
7.12.6 Lupin Competitive Strengths & Weaknesses
7.13 Fresenius Kabi AG
7.13.1 Fresenius Kabi AG Details
7.13.2 Fresenius Kabi AG Major Business
7.13.3 Fresenius Kabi AG Autoimmune Monoclonal Antibodies Product and Services
7.13.4 Fresenius Kabi AG Autoimmune Monoclonal Antibodies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Fresenius Kabi AG Recent Developments/Updates
7.13.6 Fresenius Kabi AG Competitive Strengths & Weaknesses
7.14 Akorn Incorporated
7.14.1 Akorn Incorporated Details
7.14.2 Akorn Incorporated Major Business
7.14.3 Akorn Incorporated Autoimmune Monoclonal Antibodies Product and Services
7.14.4 Akorn Incorporated Autoimmune Monoclonal Antibodies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Akorn Incorporated Recent Developments/Updates
7.14.6 Akorn Incorporated Competitive Strengths & Weaknesses
7.15 Teva Pharmaceutical Industries Ltd
7.15.1 Teva Pharmaceutical Industries Ltd Details
7.15.2 Teva Pharmaceutical Industries Ltd Major Business
7.15.3 Teva Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Product and Services
7.15.4 Teva Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.15.6 Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Autoimmune Monoclonal Antibodies and Key Manufacturers
8.2 Autoimmune Monoclonal Antibodies Manufacturing Costs
8.3 Autoimmune Monoclonal Antibodies Production Process
8.4 Autoimmune Monoclonal Antibodies Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Autoimmune Monoclonal Antibodies Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Autoimmune Monoclonal Antibodies Typical Distributors
9.3 Autoimmune Monoclonal Antibodies Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Autoimmune Monoclonal Antibodies Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Autoimmune Monoclonal Antibodies Production Value by Region (2017-2022) & (USD Million)
Table 3. World Autoimmune Monoclonal Antibodies Production Value by Region (2023-2028) & (USD Million)
Table 4. World Autoimmune Monoclonal Antibodies Production Value Market Share by Region (2017-2022)
Table 5. World Autoimmune Monoclonal Antibodies Production Value Market Share by Region (2023-2028)
Table 6. World Autoimmune Monoclonal Antibodies Production by Region (2017-2022) & (K Units)
Table 7. World Autoimmune Monoclonal Antibodies Production by Region (2023-2028) & (K Units)
Table 8. World Autoimmune Monoclonal Antibodies Production Market Share by Region (2017-2022)
Table 9. World Autoimmune Monoclonal Antibodies Production Market Share by Region (2023-2028)
Table 10. World Autoimmune Monoclonal Antibodies Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Autoimmune Monoclonal Antibodies Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Autoimmune Monoclonal Antibodies Major Market Trends
Table 13. World Autoimmune Monoclonal Antibodies Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Autoimmune Monoclonal Antibodies Consumption by Region (2017-2022) & (K Units)
Table 15. World Autoimmune Monoclonal Antibodies Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Autoimmune Monoclonal Antibodies Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Autoimmune Monoclonal Antibodies Producers in 2021
Table 18. World Autoimmune Monoclonal Antibodies Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Autoimmune Monoclonal Antibodies Producers in 2021
Table 20. World Autoimmune Monoclonal Antibodies Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Autoimmune Monoclonal Antibodies Company Evaluation Quadrant
Table 22. World Autoimmune Monoclonal Antibodies Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Autoimmune Monoclonal Antibodies Production Site of Key Manufacturer
Table 24. Autoimmune Monoclonal Antibodies Market: Company Product Type Footprint
Table 25. Autoimmune Monoclonal Antibodies Market: Company Product Application Footprint
Table 26. Autoimmune Monoclonal Antibodies Competitive Factors
Table 27. Autoimmune Monoclonal Antibodies New Entrant and Capacity Expansion Plans
Table 28. Autoimmune Monoclonal Antibodies Mergers & Acquisitions Activity
Table 29. United States VS China Autoimmune Monoclonal Antibodies Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Autoimmune Monoclonal Antibodies Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Autoimmune Monoclonal Antibodies Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Autoimmune Monoclonal Antibodies in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Autoimmune Monoclonal Antibodies Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Autoimmune Monoclonal Antibodies Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Autoimmune Monoclonal Antibodies Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Autoimmune Monoclonal Antibodies Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Autoimmune Monoclonal Antibodies in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Autoimmune Monoclonal Antibodies Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Autoimmune Monoclonal Antibodies Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Autoimmune Monoclonal Antibodies Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Autoimmune Monoclonal Antibodies Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Autoimmune Monoclonal Antibodies in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Autoimmune Monoclonal Antibodies Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Autoimmune Monoclonal Antibodies Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Autoimmune Monoclonal Antibodies Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Autoimmune Monoclonal Antibodies Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Autoimmune Monoclonal Antibodies Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Autoimmune Monoclonal Antibodies Production by Type (2017-2022) & (K Units)
Table 49. World Autoimmune Monoclonal Antibodies Production by Type (2023-2028) & (K Units)
Table 50. World Autoimmune Monoclonal Antibodies Production Value by Type (2017-2022) & (USD Million)
Table 51. World Autoimmune Monoclonal Antibodies Production Value by Type (2023-2028) & (USD Million)
Table 52. World Autoimmune Monoclonal Antibodies Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Autoimmune Monoclonal Antibodies Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Autoimmune Monoclonal Antibodies Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Autoimmune Monoclonal Antibodies Production by Application (2017-2022) & (K Units)
Table 56. World Autoimmune Monoclonal Antibodies Production by Application (2023-2028) & (K Units)
Table 57. World Autoimmune Monoclonal Antibodies Production Value by Application (2017-2022) & (USD Million)
Table 58. World Autoimmune Monoclonal Antibodies Production Value by Application (2023-2028) & (USD Million)
Table 59. World Autoimmune Monoclonal Antibodies Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Autoimmune Monoclonal Antibodies Average Price by Application (2023-2028) & (US$/Unit)
Table 61. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 62. F. Hoffmann-La Roche Ltd Major Business
Table 63. F. Hoffmann-La Roche Ltd Autoimmune Monoclonal Antibodies Product and Services
Table 64. F. Hoffmann-La Roche Ltd Autoimmune Monoclonal Antibodies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 66. F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
Table 67. Mylan N.V Basic Information, Manufacturing Base and Competitors
Table 68. Mylan N.V Major Business
Table 69. Mylan N.V Autoimmune Monoclonal Antibodies Product and Services
Table 70. Mylan N.V Autoimmune Monoclonal Antibodies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Mylan N.V Recent Developments/Updates
Table 72. Mylan N.V Competitive Strengths & Weaknesses
Table 73. Sanofi Basic Information, Manufacturing Base and Competitors
Table 74. Sanofi Major Business
Table 75. Sanofi Autoimmune Monoclonal Antibodies Product and Services
Table 76. Sanofi Autoimmune Monoclonal Antibodies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Sanofi Recent Developments/Updates
Table 78. Sanofi Competitive Strengths & Weaknesses
Table 79. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 80. Pfizer Inc Major Business
Table 81. Pfizer Inc Autoimmune Monoclonal Antibodies Product and Services
Table 82. Pfizer Inc Autoimmune Monoclonal Antibodies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Pfizer Inc Recent Developments/Updates
Table 84. Pfizer Inc Competitive Strengths & Weaknesses
Table 85. GSK plc Basic Information, Manufacturing Base and Competitors
Table 86. GSK plc Major Business
Table 87. GSK plc Autoimmune Monoclonal Antibodies Product and Services
Table 88. GSK plc Autoimmune Monoclonal Antibodies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. GSK plc Recent Developments/Updates
Table 90. GSK plc Competitive Strengths & Weaknesses
Table 91. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 92. Novartis AG Major Business
Table 93. Novartis AG Autoimmune Monoclonal Antibodies Product and Services
Table 94. Novartis AG Autoimmune Monoclonal Antibodies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Novartis AG Recent Developments/Updates
Table 96. Novartis AG Competitive Strengths & Weaknesses
Table 97. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 98. Bayer AG Major Business
Table 99. Bayer AG Autoimmune Monoclonal Antibodies Product and Services
Table 100. Bayer AG Autoimmune Monoclonal Antibodies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Bayer AG Recent Developments/Updates
Table 102. Bayer AG Competitive Strengths & Weaknesses
Table 103. Lilly Basic Information, Manufacturing Base and Competitors
Table 104. Lilly Major Business
Table 105. Lilly Autoimmune Monoclonal Antibodies Product and Services
Table 106. Lilly Autoimmune Monoclonal Antibodies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Lilly Recent Developments/Updates
Table 108. Lilly Competitive Strengths & Weaknesses
Table 109. Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table 110. Merck & Co., Inc Major Business
Table 111. Merck & Co., Inc Autoimmune Monoclonal Antibodies Product and Services
Table 112. Merck & Co., Inc Autoimmune Monoclonal Antibodies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Merck & Co., Inc Recent Developments/Updates
Table 114. Merck & Co., Inc Competitive Strengths & Weaknesses
Table 115. Sun Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 116. Sun Pharmaceutical Industries Ltd Major Business
Table 117. Sun Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Product and Services
Table 118. Sun Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
Table 120. Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 121. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 122. Aurobindo Pharma Major Business
Table 123. Aurobindo Pharma Autoimmune Monoclonal Antibodies Product and Services
Table 124. Aurobindo Pharma Autoimmune Monoclonal Antibodies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Aurobindo Pharma Recent Developments/Updates
Table 126. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 127. Lupin Basic Information, Manufacturing Base and Competitors
Table 128. Lupin Major Business
Table 129. Lupin Autoimmune Monoclonal Antibodies Product and Services
Table 130. Lupin Autoimmune Monoclonal Antibodies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Lupin Recent Developments/Updates
Table 132. Lupin Competitive Strengths & Weaknesses
Table 133. Fresenius Kabi AG Basic Information, Manufacturing Base and Competitors
Table 134. Fresenius Kabi AG Major Business
Table 135. Fresenius Kabi AG Autoimmune Monoclonal Antibodies Product and Services
Table 136. Fresenius Kabi AG Autoimmune Monoclonal Antibodies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Fresenius Kabi AG Recent Developments/Updates
Table 138. Fresenius Kabi AG Competitive Strengths & Weaknesses
Table 139. Akorn Incorporated Basic Information, Manufacturing Base and Competitors
Table 140. Akorn Incorporated Major Business
Table 141. Akorn Incorporated Autoimmune Monoclonal Antibodies Product and Services
Table 142. Akorn Incorporated Autoimmune Monoclonal Antibodies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Akorn Incorporated Recent Developments/Updates
Table 144. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 145. Teva Pharmaceutical Industries Ltd Major Business
Table 146. Teva Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Product and Services
Table 147. Teva Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 148. Autoimmune Monoclonal Antibodies Raw Material
Table 149. Key Manufacturers of Autoimmune Monoclonal Antibodies Raw Materials
Table 150. Autoimmune Monoclonal Antibodies Typical Distributors
Table 151. Autoimmune Monoclonal Antibodies Typical Customers
Table 1. World Autoimmune Monoclonal Antibodies Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Autoimmune Monoclonal Antibodies Production Value by Region (2017-2022) & (USD Million)
Table 3. World Autoimmune Monoclonal Antibodies Production Value by Region (2023-2028) & (USD Million)
Table 4. World Autoimmune Monoclonal Antibodies Production Value Market Share by Region (2017-2022)
Table 5. World Autoimmune Monoclonal Antibodies Production Value Market Share by Region (2023-2028)
Table 6. World Autoimmune Monoclonal Antibodies Production by Region (2017-2022) & (K Units)
Table 7. World Autoimmune Monoclonal Antibodies Production by Region (2023-2028) & (K Units)
Table 8. World Autoimmune Monoclonal Antibodies Production Market Share by Region (2017-2022)
Table 9. World Autoimmune Monoclonal Antibodies Production Market Share by Region (2023-2028)
Table 10. World Autoimmune Monoclonal Antibodies Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Autoimmune Monoclonal Antibodies Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Autoimmune Monoclonal Antibodies Major Market Trends
Table 13. World Autoimmune Monoclonal Antibodies Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Autoimmune Monoclonal Antibodies Consumption by Region (2017-2022) & (K Units)
Table 15. World Autoimmune Monoclonal Antibodies Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Autoimmune Monoclonal Antibodies Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Autoimmune Monoclonal Antibodies Producers in 2021
Table 18. World Autoimmune Monoclonal Antibodies Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Autoimmune Monoclonal Antibodies Producers in 2021
Table 20. World Autoimmune Monoclonal Antibodies Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Autoimmune Monoclonal Antibodies Company Evaluation Quadrant
Table 22. World Autoimmune Monoclonal Antibodies Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Autoimmune Monoclonal Antibodies Production Site of Key Manufacturer
Table 24. Autoimmune Monoclonal Antibodies Market: Company Product Type Footprint
Table 25. Autoimmune Monoclonal Antibodies Market: Company Product Application Footprint
Table 26. Autoimmune Monoclonal Antibodies Competitive Factors
Table 27. Autoimmune Monoclonal Antibodies New Entrant and Capacity Expansion Plans
Table 28. Autoimmune Monoclonal Antibodies Mergers & Acquisitions Activity
Table 29. United States VS China Autoimmune Monoclonal Antibodies Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Autoimmune Monoclonal Antibodies Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Autoimmune Monoclonal Antibodies Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Autoimmune Monoclonal Antibodies in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Autoimmune Monoclonal Antibodies Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Autoimmune Monoclonal Antibodies Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Autoimmune Monoclonal Antibodies Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Autoimmune Monoclonal Antibodies Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Autoimmune Monoclonal Antibodies in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Autoimmune Monoclonal Antibodies Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Autoimmune Monoclonal Antibodies Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Autoimmune Monoclonal Antibodies Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Autoimmune Monoclonal Antibodies Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Autoimmune Monoclonal Antibodies in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Autoimmune Monoclonal Antibodies Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Autoimmune Monoclonal Antibodies Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Autoimmune Monoclonal Antibodies Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Autoimmune Monoclonal Antibodies Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Autoimmune Monoclonal Antibodies Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Autoimmune Monoclonal Antibodies Production by Type (2017-2022) & (K Units)
Table 49. World Autoimmune Monoclonal Antibodies Production by Type (2023-2028) & (K Units)
Table 50. World Autoimmune Monoclonal Antibodies Production Value by Type (2017-2022) & (USD Million)
Table 51. World Autoimmune Monoclonal Antibodies Production Value by Type (2023-2028) & (USD Million)
Table 52. World Autoimmune Monoclonal Antibodies Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Autoimmune Monoclonal Antibodies Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Autoimmune Monoclonal Antibodies Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Autoimmune Monoclonal Antibodies Production by Application (2017-2022) & (K Units)
Table 56. World Autoimmune Monoclonal Antibodies Production by Application (2023-2028) & (K Units)
Table 57. World Autoimmune Monoclonal Antibodies Production Value by Application (2017-2022) & (USD Million)
Table 58. World Autoimmune Monoclonal Antibodies Production Value by Application (2023-2028) & (USD Million)
Table 59. World Autoimmune Monoclonal Antibodies Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Autoimmune Monoclonal Antibodies Average Price by Application (2023-2028) & (US$/Unit)
Table 61. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 62. F. Hoffmann-La Roche Ltd Major Business
Table 63. F. Hoffmann-La Roche Ltd Autoimmune Monoclonal Antibodies Product and Services
Table 64. F. Hoffmann-La Roche Ltd Autoimmune Monoclonal Antibodies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 66. F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
Table 67. Mylan N.V Basic Information, Manufacturing Base and Competitors
Table 68. Mylan N.V Major Business
Table 69. Mylan N.V Autoimmune Monoclonal Antibodies Product and Services
Table 70. Mylan N.V Autoimmune Monoclonal Antibodies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Mylan N.V Recent Developments/Updates
Table 72. Mylan N.V Competitive Strengths & Weaknesses
Table 73. Sanofi Basic Information, Manufacturing Base and Competitors
Table 74. Sanofi Major Business
Table 75. Sanofi Autoimmune Monoclonal Antibodies Product and Services
Table 76. Sanofi Autoimmune Monoclonal Antibodies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Sanofi Recent Developments/Updates
Table 78. Sanofi Competitive Strengths & Weaknesses
Table 79. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 80. Pfizer Inc Major Business
Table 81. Pfizer Inc Autoimmune Monoclonal Antibodies Product and Services
Table 82. Pfizer Inc Autoimmune Monoclonal Antibodies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Pfizer Inc Recent Developments/Updates
Table 84. Pfizer Inc Competitive Strengths & Weaknesses
Table 85. GSK plc Basic Information, Manufacturing Base and Competitors
Table 86. GSK plc Major Business
Table 87. GSK plc Autoimmune Monoclonal Antibodies Product and Services
Table 88. GSK plc Autoimmune Monoclonal Antibodies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. GSK plc Recent Developments/Updates
Table 90. GSK plc Competitive Strengths & Weaknesses
Table 91. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 92. Novartis AG Major Business
Table 93. Novartis AG Autoimmune Monoclonal Antibodies Product and Services
Table 94. Novartis AG Autoimmune Monoclonal Antibodies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Novartis AG Recent Developments/Updates
Table 96. Novartis AG Competitive Strengths & Weaknesses
Table 97. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 98. Bayer AG Major Business
Table 99. Bayer AG Autoimmune Monoclonal Antibodies Product and Services
Table 100. Bayer AG Autoimmune Monoclonal Antibodies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Bayer AG Recent Developments/Updates
Table 102. Bayer AG Competitive Strengths & Weaknesses
Table 103. Lilly Basic Information, Manufacturing Base and Competitors
Table 104. Lilly Major Business
Table 105. Lilly Autoimmune Monoclonal Antibodies Product and Services
Table 106. Lilly Autoimmune Monoclonal Antibodies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Lilly Recent Developments/Updates
Table 108. Lilly Competitive Strengths & Weaknesses
Table 109. Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table 110. Merck & Co., Inc Major Business
Table 111. Merck & Co., Inc Autoimmune Monoclonal Antibodies Product and Services
Table 112. Merck & Co., Inc Autoimmune Monoclonal Antibodies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Merck & Co., Inc Recent Developments/Updates
Table 114. Merck & Co., Inc Competitive Strengths & Weaknesses
Table 115. Sun Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 116. Sun Pharmaceutical Industries Ltd Major Business
Table 117. Sun Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Product and Services
Table 118. Sun Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
Table 120. Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 121. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 122. Aurobindo Pharma Major Business
Table 123. Aurobindo Pharma Autoimmune Monoclonal Antibodies Product and Services
Table 124. Aurobindo Pharma Autoimmune Monoclonal Antibodies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Aurobindo Pharma Recent Developments/Updates
Table 126. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 127. Lupin Basic Information, Manufacturing Base and Competitors
Table 128. Lupin Major Business
Table 129. Lupin Autoimmune Monoclonal Antibodies Product and Services
Table 130. Lupin Autoimmune Monoclonal Antibodies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Lupin Recent Developments/Updates
Table 132. Lupin Competitive Strengths & Weaknesses
Table 133. Fresenius Kabi AG Basic Information, Manufacturing Base and Competitors
Table 134. Fresenius Kabi AG Major Business
Table 135. Fresenius Kabi AG Autoimmune Monoclonal Antibodies Product and Services
Table 136. Fresenius Kabi AG Autoimmune Monoclonal Antibodies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Fresenius Kabi AG Recent Developments/Updates
Table 138. Fresenius Kabi AG Competitive Strengths & Weaknesses
Table 139. Akorn Incorporated Basic Information, Manufacturing Base and Competitors
Table 140. Akorn Incorporated Major Business
Table 141. Akorn Incorporated Autoimmune Monoclonal Antibodies Product and Services
Table 142. Akorn Incorporated Autoimmune Monoclonal Antibodies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Akorn Incorporated Recent Developments/Updates
Table 144. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 145. Teva Pharmaceutical Industries Ltd Major Business
Table 146. Teva Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Product and Services
Table 147. Teva Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 148. Autoimmune Monoclonal Antibodies Raw Material
Table 149. Key Manufacturers of Autoimmune Monoclonal Antibodies Raw Materials
Table 150. Autoimmune Monoclonal Antibodies Typical Distributors
Table 151. Autoimmune Monoclonal Antibodies Typical Customers
LIST OF FIGURES
Figure 1. Autoimmune Monoclonal Antibodies Picture
Figure 2. World Autoimmune Monoclonal Antibodies Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Autoimmune Monoclonal Antibodies Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Autoimmune Monoclonal Antibodies Production (2017-2028) & (K Units)
Figure 5. World Autoimmune Monoclonal Antibodies Average Price (2017-2028) & (US$/Unit)
Figure 6. World Autoimmune Monoclonal Antibodies Production Value Market Share by Region (2017-2028)
Figure 7. World Autoimmune Monoclonal Antibodies Production Market Share by Region (2017-2028)
Figure 8. North America Autoimmune Monoclonal Antibodies Production (2017-2028) & (K Units)
Figure 9. Europe Autoimmune Monoclonal Antibodies Production (2017-2028) & (K Units)
Figure 10. China Autoimmune Monoclonal Antibodies Production (2017-2028) & (K Units)
Figure 11. Japan Autoimmune Monoclonal Antibodies Production (2017-2028) & (K Units)
Figure 12. Autoimmune Monoclonal Antibodies Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Autoimmune Monoclonal Antibodies Demand (2017-2028) & (K Units)
Figure 15. World Autoimmune Monoclonal Antibodies Consumption Market Share by Region (2017-2028)
Figure 16. United States Autoimmune Monoclonal Antibodies Consumption (2017-2028) & (K Units)
Figure 17. China Autoimmune Monoclonal Antibodies Consumption (2017-2028) & (K Units)
Figure 18. Europe Autoimmune Monoclonal Antibodies Consumption (2017-2028) & (K Units)
Figure 19. Japan Autoimmune Monoclonal Antibodies Consumption (2017-2028) & (K Units)
Figure 20. South Korea Autoimmune Monoclonal Antibodies Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Autoimmune Monoclonal Antibodies Consumption (2017-2028) & (K Units)
Figure 22. India Autoimmune Monoclonal Antibodies Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Autoimmune Monoclonal Antibodies by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Autoimmune Monoclonal Antibodies Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Autoimmune Monoclonal Antibodies Markets in 2021
Figure 26. United States VS China: Autoimmune Monoclonal Antibodies Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Autoimmune Monoclonal Antibodies Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Autoimmune Monoclonal Antibodies Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Autoimmune Monoclonal Antibodies in United States
Figure 30. Key Producers and Market Share of Autoimmune Monoclonal Antibodies in China
Figure 31. Key Producers and Market Share of Autoimmune Monoclonal Antibodies in Rest of World
Figure 32. World Autoimmune Monoclonal Antibodies Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Autoimmune Monoclonal Antibodies Production Value Market Share by Type in 2021
Figure 34. TNF Class
Figure 35. Interleukins
Figure 36. Integrins
Figure 37. B-Cell Depletion and Inhibition Targets
Figure 38. T Cell Depletion Targets
Figure 39. World Autoimmune Monoclonal Antibodies Production Market Share by Type (2017-2028)
Figure 40. World Autoimmune Monoclonal Antibodies Production Value Market Share by Type (2017-2028)
Figure 41. World Autoimmune Monoclonal Antibodies Average Price by Type (2017-2028) & (US$/Unit)
Figure 42. World Autoimmune Monoclonal Antibodies Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 43. World Autoimmune Monoclonal Antibodies Production Value Market Share by Application in 2021
Figure 44. Rheumatoid Arthritis
Figure 45. Systemic Lupus Erythematosus
Figure 46. Multiple Sclerosis
Figure 47. Organ Transplant Rejection
Figure 48. Others
Figure 49. World Autoimmune Monoclonal Antibodies Production Market Share by Application (2017-2028)
Figure 50. World Autoimmune Monoclonal Antibodies Production Value Market Share by Application (2017-2028)
Figure 51. World Autoimmune Monoclonal Antibodies Average Price by Application (2017-2028) & (US$/Unit)
Figure 52. Manufacturing Cost Structure Analysis of Autoimmune Monoclonal Antibodies in 2021
Figure 53. Manufacturing Process Analysis of Autoimmune Monoclonal Antibodies
Figure 54. Autoimmune Monoclonal Antibodies Industrial Chain
Figure 55. Distribution Channel Breakdown for Autoimmune Monoclonal Antibodies Shipments (%): 2017-2028
Figure 56. Direct Channel Pros & Cons
Figure 57. Indirect Channel Pros & Cons
Figure 58. Methodology
Figure 59. Research Process and Data Source
Figure 1. Autoimmune Monoclonal Antibodies Picture
Figure 2. World Autoimmune Monoclonal Antibodies Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Autoimmune Monoclonal Antibodies Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Autoimmune Monoclonal Antibodies Production (2017-2028) & (K Units)
Figure 5. World Autoimmune Monoclonal Antibodies Average Price (2017-2028) & (US$/Unit)
Figure 6. World Autoimmune Monoclonal Antibodies Production Value Market Share by Region (2017-2028)
Figure 7. World Autoimmune Monoclonal Antibodies Production Market Share by Region (2017-2028)
Figure 8. North America Autoimmune Monoclonal Antibodies Production (2017-2028) & (K Units)
Figure 9. Europe Autoimmune Monoclonal Antibodies Production (2017-2028) & (K Units)
Figure 10. China Autoimmune Monoclonal Antibodies Production (2017-2028) & (K Units)
Figure 11. Japan Autoimmune Monoclonal Antibodies Production (2017-2028) & (K Units)
Figure 12. Autoimmune Monoclonal Antibodies Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Autoimmune Monoclonal Antibodies Demand (2017-2028) & (K Units)
Figure 15. World Autoimmune Monoclonal Antibodies Consumption Market Share by Region (2017-2028)
Figure 16. United States Autoimmune Monoclonal Antibodies Consumption (2017-2028) & (K Units)
Figure 17. China Autoimmune Monoclonal Antibodies Consumption (2017-2028) & (K Units)
Figure 18. Europe Autoimmune Monoclonal Antibodies Consumption (2017-2028) & (K Units)
Figure 19. Japan Autoimmune Monoclonal Antibodies Consumption (2017-2028) & (K Units)
Figure 20. South Korea Autoimmune Monoclonal Antibodies Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Autoimmune Monoclonal Antibodies Consumption (2017-2028) & (K Units)
Figure 22. India Autoimmune Monoclonal Antibodies Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Autoimmune Monoclonal Antibodies by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Autoimmune Monoclonal Antibodies Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Autoimmune Monoclonal Antibodies Markets in 2021
Figure 26. United States VS China: Autoimmune Monoclonal Antibodies Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Autoimmune Monoclonal Antibodies Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Autoimmune Monoclonal Antibodies Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Autoimmune Monoclonal Antibodies in United States
Figure 30. Key Producers and Market Share of Autoimmune Monoclonal Antibodies in China
Figure 31. Key Producers and Market Share of Autoimmune Monoclonal Antibodies in Rest of World
Figure 32. World Autoimmune Monoclonal Antibodies Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Autoimmune Monoclonal Antibodies Production Value Market Share by Type in 2021
Figure 34. TNF Class
Figure 35. Interleukins
Figure 36. Integrins
Figure 37. B-Cell Depletion and Inhibition Targets
Figure 38. T Cell Depletion Targets
Figure 39. World Autoimmune Monoclonal Antibodies Production Market Share by Type (2017-2028)
Figure 40. World Autoimmune Monoclonal Antibodies Production Value Market Share by Type (2017-2028)
Figure 41. World Autoimmune Monoclonal Antibodies Average Price by Type (2017-2028) & (US$/Unit)
Figure 42. World Autoimmune Monoclonal Antibodies Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 43. World Autoimmune Monoclonal Antibodies Production Value Market Share by Application in 2021
Figure 44. Rheumatoid Arthritis
Figure 45. Systemic Lupus Erythematosus
Figure 46. Multiple Sclerosis
Figure 47. Organ Transplant Rejection
Figure 48. Others
Figure 49. World Autoimmune Monoclonal Antibodies Production Market Share by Application (2017-2028)
Figure 50. World Autoimmune Monoclonal Antibodies Production Value Market Share by Application (2017-2028)
Figure 51. World Autoimmune Monoclonal Antibodies Average Price by Application (2017-2028) & (US$/Unit)
Figure 52. Manufacturing Cost Structure Analysis of Autoimmune Monoclonal Antibodies in 2021
Figure 53. Manufacturing Process Analysis of Autoimmune Monoclonal Antibodies
Figure 54. Autoimmune Monoclonal Antibodies Industrial Chain
Figure 55. Distribution Channel Breakdown for Autoimmune Monoclonal Antibodies Shipments (%): 2017-2028
Figure 56. Direct Channel Pros & Cons
Figure 57. Indirect Channel Pros & Cons
Figure 58. Methodology
Figure 59. Research Process and Data Source
